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Introduction
The immune system serves more than just to “defend” against disease. The immune system was designed to interact with
microbes and to cleanse the body of aging, dying, and dead red blood cells and bacteria even in the pre-fall world. The immune
system in a pre-fall world worked to assist body development positively, and in the post-fall world, it also defends against
pathogens. This is how most creation biologists view the immune system.

THE MOST PROBABLE PRE-FALL FUNCTION OF ANTIBODIES IS TO REGULATE NUMBERS OF
MICROBES AND SHAPE THE MICROBIOME COMPOSITION.
The most probable pre-fall function of antibodies is to regulate numbers of microbes and shape the microbiome composition.
Too much of even a good thing is bad. Even in a perfect world, the grass and trees might need to be trimmed—and grazing animals
would take care of much of this. In the body, antibodies could be used to keep good E. coli at the right numbers in the gut. There
were no harmful pre-fall bacteria, so the numbers would need to be regulated.
In recent research, host antibodies shape gut microbiome by changing bacteria gene expression.1 The researchers have
discovered how antibodies secreted in the gut promote the growth of bene cial bacteria. Their study, published in the Journal of
Experimental Medicine (JEM), shows that immunoglobulin A (IgA) antibodies can alter the expression of bacterial genes, allowing
different bacterial species to cooperate with each other and form a community that enhances body function.
It is estimated that between two and ve grams of IgA are produced in adult intestines each day. IgA is the rst line of defense
against harmful, pathogenic bacteria in the gastrointestinal tract, but it also promotes the growth of a healthy microbiome—the
community of “good” bacteria that reside in the gut. An average adult has over two thousand species of bacteria in their intestines
that improve the function of the intestines and immune system, signi cantly impacting human health and disease.2 Even in a pre-

fall world, humans and animals would have utilized antibodies to
regulate the gut microbiome. The prominent human gut bacterium
Bacteroides thetaiotaomicron (B. theta, g. 1) was particularly susceptible
to coating with gut antibodies, IgA. The JEM team discovered that
exposure to IgA causes B. theta to up-regulate two proteins that were
structurally shared with many other bacterial strains, named MucusAssociated Functional Factors (MAFFs).3 These proteins appear to
help B. theta grow in the mucous membrane of the intestine and
produce metabolites that allow other bene cial bacteria, such as those
in the group Clostridiales (gut bacteria taxa), to thrive as well. Mice
inoculated with a strain of B. theta unable to up-regulate MAFFs had an
altered gut microbiome and were more susceptible to intestinal
in ammation, or colitis.
Fig. 1. Bacteroides. Image Credit: CNX OpenStax (labeled
as OSC Microbio 04 03 bacteroide.jpg), via Wikimedia
Commons.

Table 1. Fast Facts About the Five Types of Antibodies
Type

Property

IgG

Most abundant; circulates in the blood, lymph, and intestine; most pronounced in immunization; rst and main antibody produced in the fetus; crosses placenta; neutralizes
viruses and toxins; principal component of secondary response from the vaccine; enhances phagocytosis

IgM

Largest of antibodies; circulates in the blood and lymph on
B cell surface; principal component of primary response
from the vaccine; complement xation; effective in agglutinating (clotting) antigens

IgA

Found mainly in secretions such as mucus, tears, saliva,
milk; numerous in respiratory infections

IgD

Found on the surface of various cells; facilitates maturation of the antibody response; antigen receptor on B cells

IgE

Involved in hypersensitivity and allergy reactions; also involved in multicellular parasitic infections

Antibodies
There is an antibody-mediated defense found in blood plasma, lymph, and other body uids. In adaptive (acquired) immunity,
receptors provide pathogen-speci c recognition. It is a speci c lock-and-key t. Antibodies have locked away the secret of
defeating each disease; a second infection of the same type will normally do no or minimal harm. It is immunity attributable to
speci c antibodies in blood plasma. B cells act as the “biological arms factory,” designed to produce millions of potent, speci c
antibodies. Antibodies and helper T cells often work together during immune responses. Upon activation by an antigen, B cells
collectively undergo differentiation, each producing hundreds of speci c antibodies, proteins made in response to speci c
antigens, then recognize and bind tightly to them ( g. 2a). Antibodies can, therefore, help neutralize or destroy antigens.
Antibodies belong to the soluble-proteins known as immunoglobulins or Igs. Five classes of immunoglobulins are designated IgG,
IgM, IgA, IgE, and IgD. Antibodies have at least two identical sites that bind to antigenic determinants. These sites are known as
antigen-binding or antibody-combining. The number of antigen-binding sites on an antibody is called the valence of that antibody.
For example, most antibodies have two binding sites, so they are said to be bivalent. By design, each class plays a different role in
the immune response and has a distinctive size and shape.
Antibodies are comprised of light (L) and heavy (H) chains attached by disul de bonds. The most common antibody is IgG,
composed of four polypeptide chains: two identical light chains and two identical heavy chains. These chains are arranged in a Y

shape. The two tips of the Y vary from antibody to antibody, and these
tips allow the antibody to attack one kind of antigen speci cally. These
tips, called the variable regions or antigen-binding sites, are the point
where the antibody binds to the antigen with the speci city of a key
tting its lock. The rest of each chain in the antibody is called the
constant region ( g. 2b). The characteristics of the constant region
determine the class of the antibody (Gillen 2019).
Each class ghts antigens in a slightly different way. IgG helps promote
phagocytosis, for example. They bind to the antigen with their variable
regions and to macrophages with their constant region, then
macrophages engulf the antigen. IgMs are larger antibodies that form a
ve-antibody complex and use their constant regions to activate
complement proteins. Interestingly, IgG can also ght antigens this
way. IgE helps initiate the in ammatory response by rst attaching to
basophils with their constant regions. Then, when attached to antigens
with their variable regions, the basophils are stimulated to release
in ammatory agents. IgA is found in breast milk to provide immunity to
infants. IgD typically inactivates antigens by simple binding.
Antibodies, then, have several means of ghting antigens:
1. Binding directly to the antigen.
2. Binding the antigens together in groups.
3. Activating complement.
4. Stimulating phagocytosis.
5. Stimulating in ammation.

Fig. 2a. Image Credit: DigitalShuttermonkey (labeled as
Antibody illustration.svg), via Wikimedia Commons.

Mounting and Maintaining a Response
In the event of a new threat, a B lymphocyte cell memorizes the shape
and rushes to the nearest lymph node or gland, and it is transformed
into a plasma cell that is a chemical antibody factory. One speci c
antibody subtype is for one pathogen or parasite and stores the
formula to overcome the germ. Occasionally, a new antigen comes
along and “fools” the body’s response. The cells have to adapt and
modify their formula to come up with a new combination and combat
the threat.

THE VARIABLE REGION OF AN ANTIBODY
DETERMINES THE SPECIFIC ANTIGEN IT WILL
FIGHT. THE CONSTANT REGION DETERMINES THE
METHOD BY WHICH IT WILL FIGHT THE ANTIGEN.

Fig. 2b. Image Credit: Fvasconcellos (labeled as Antibody.svg), via Wikimedia Commons.

The variable region of an antibody determines the speci c antigen it
will ght. The constant region determines the method by which it will ght the antigen. Antibodies are produced by B cells—
specialized lymphocytes. Antigen-antibody binding causes these B cells to divide rapidly. This process is called clonal selection
because the resulting population of cells is composed of replicates that multiply in the presence of particular invasive antigens.
When exposed for the rst time to the antigen for which they are speci c, these sites bind to the antigen, and the B cells begin to
proliferate. The proliferation produces two types of B cells: plasma B cells and memory B cells. The activated plasma cells are
large ellipsoidal or spherical cells that may reach 20 μm in diameter. They undergo morphologic change mainly due to the rough

endoplasmic reticulum (RER), which must expand to provide increased surface area for active protein synthesis. Antibodies are
membrane bound, and clonal selection causes those cells that have an antibody that recognizes the antigens to undergo the
transformation to plasma cells. While some are transformed into plasma cells, others remain as memory cells.
The antibodies are released into the plasma so the antibodies can attack the antigens to which they can bind. The memory B cells
are long-lived cells that do not release their antibodies. Instead, they circulate in the body waiting for the next attack by the
antigen, allowing the body to respond quickly to subsequent infection by the same antigen. These cells give the immune system its
amazing memory.
With each such subsequent exposure to the same antigen, the number of different responding B cell clones increases to generate
a many-clone response, and effectively a greater number of memory B cells persist. Thus, a stronger antibody response (i.e., higher
antibody titer) having improved af nity towards antigen is typically observed in the secondary immune response. The fact that all
the accumulation of cells of a single clone population expresses many of the same types of antibody and that these memory B cells
survive for long periods in a body underscores their functional signi cance during vaccination and the administration of booster
shots. In the case of smallpox, it has been documented 50 years in memory for B cells and documented for as long as 70 years in
memory for T cells.
Memory B lymphocytes are generated at three speci c germinal centers in the bone marrow.
Memory B cells contribute to a bigger and faster antibody response than regular B cells in primary response because they have
already undergone class switching (mature) and have a faster and higher af nity than immature B cells. They still have to
proliferate into plasma cells that have high antibody production due to rich cell RER. IgG is faster, bigger, better defense against
speci c pathogens and parasites. Antibody production shows beauty, complexity, providential orderliness, and gives praise as a
fearfully and wonderfully made design.

Variation on a Theme: G.O.D.: Generator of (Antibody) Diversity
IMMUNOLOGISTS, LIKE DR. RONALD GLASSER, JOKE ABOUT ANTIBODY DIVERSITY
ACRONYM, GOD (GENERATOR OF DIVERSITY). THIS EXPRESSES THE BODY’S ASTONISHING
ABILITY TO MANUFACTURE WHAT DEFENSE IS NEEDED TO GET THE JOB DONE AGAINST
INVADING PATHOGENS AND PARASITES.
Immunologists, like Dr. Ronald Glasser,4 joke about antibody diversity acronym, GOD (Generator of Diversity). This expresses the
body’s astonishing ability to manufacture what defense is needed to get the job done against invading pathogens and parasites.
Dr. Glasser says that the mixture is “a mixture of mystery and chemistry… a combination of physics and grace at the molecular
level” (Brand and Yancy 1984, p. 85). The diversity helps with the staggering range of invaders (virus, bacteria, fungi, protozoan,
and multi-cellular parasites). There is an enormous number of threats over time.
Antibody diversity is a result of gene rearrangement. There may be an estimate of more than a million different antibody types.
For decades, immunologists were puzzled over how an enormous variety of antibodies could be generated by the limited number
of genes associated with the immune system. Because, like all proteins, genes specify antibodies, it would be reasonable to assume
that an individual must have a million or more antibody genes. However, genomic experts point out that human cells have only
about 35,000 genes. The answer to this antibody diversity mystery is elegant and simple, pointing clearly to intelligent design and
a benevolent Creator.

Building Blocks
Embryonic cells contain about 300 genetic segments that can be shuf ed and combined in each B lymphocyte as it matures. The
process, known as somatic recombination or rearrangement, is a random mixing and matching of gene segments to fashion unique
antibody genes. The information encoded by these genes is then expressed on the surface receptor proteins of B lymphocytes and
in the antibodies later expressed by the stimulated clone of plasma cells. This is a process of somatic recombination, and the
discovery of immunoglobin genes for D, V, J, and C regions allow for the great variation of antibody diversity. According to the
process, the gene segments coding for the light and heavy chains of an antibody are located on different chromosomes. The light

and heavy chains are synthesized separately, then joined to form the antibody. One of eight constant genes (C), one of four joiner
genes (J), one of 50 diversity genes (D), and one of up to 300 variable genes (V) can be used to form a heavy chain. One of 300
variable genes is selected and combined with one of ve joiner genes and a constant gene to form the active light-chain gene.
After the deletion of intervening genes, the new gene can function in protein synthesis. When these gene sections are joined, new
information, not originally encoded, is added by the enzyme terminal transferase. This is the point where the system can generate
the greatest amount of diversity. That all this gene rearrangement is done at the DNA level. Class switching is a design feature able
to place the same antigen-binding site with a different class with a different role. In antibody class switching, there is a design that
changes a B-lymphocyte production of immunoglobulin from one type to another, e.g., the IgM to the IgG. During this process, the
constant-region portion of the antibody-heavy chain is changed, but the variable region of the heavy chain stays the same (the
terms “variable” and “constant” refer to changes or lack thereof between antibodies that target different epitopes). Since the
variable region does not change, class switching does not affect antigen speci city. Instead, the antibody retains af nity for the
same germs (antigens). For example, in the novel Coronavirus, IgM is produced the rst day, but later, IgG to the same virus is
produced easily because of class switching. Class switching takes place at the RNA level so that there is increased speci city and
adaptability
This discovery was insightful because it questioned two dogmas of biology: that the DNA for a protein must be one continuous
piece (for antibody synthesis, the gene segments are separated from each other, then assembled together), and that every body
cell has identical DNA (the antibody genes for different B lymphocytes can differ). Current evidence suggests that more than 600
different antibody gene segments exist per cell. Additional versatility is generated through imprecise recombination and somatic
mutation. Therefore, the total antibody diversity produced by the B cells ranges from 100 to more than 1,000 immunoglobulin
possibilities.
This system of producing enormous numbers of antibody types is clearly one of intelligent design. One analogy to this is the
principle of variation, as found in classical music. For example, J.S. Bach composed selections such as Jesu, Joy of Man’s Desiring, and
Variations on a Theme for church choirs. You might hear a basic pleasant melody, then re-encounter it in a different way and
conclude this is a detailed, masterful arrangement of music. Nature also selects from “successful” structures and varies them in
many wondrous ways for survival, even in this fallen world. Just as Bach composed beautiful music, the Creator has composed a
variation on an antibody theme that defends the body.

Antibody Relevance to Coronavirus Outbreak
The current outbreak of the 2019 Novel Coronavirus (2019-nCoV ( g.
3), upper-respiratory-tract illness rst started in Wuhan, China, and
cases have been escalating worldwide. Early on, with many cases in
Wuhan, China, it was reported that the outbreak had some association
with animal markets, which indicated that there was animal-to-person
transmission. The most likely animals with coronavirus are bats.
Presently, there is no speci c antiviral treatment for the 2019-nCoV
infection. A vaccine designed to combat severe acute respiratory
syndrome (SARS) and the advancement of technology are likely to
quicken the time to develop a new vaccine against the 2019-nCoV and
will be designed to promote antibodies to battle with this novel
coronavirus. Mercifully, there are some cases where people were able
to surpass this infection due to their intelligently designed body
defense mechanism. An antibody test (such as a sandwich E.L.I.S.A.) will
enable us to detect infections so we can portray how widespread the
virus is and consequently, determine the true morbidity and mortality
rate.

“Chinese of cials released the genome sequence of this novel coronavirus, which is helpful for diagnosis, however, having the real virus
means we now have the ability to actually validate and verify all test
methods, and compare their sensitivities and speci cities—it will be a
game changer for diagnosis.” . . . The team believes the efforts will help

Fig. 3. Coronavirus (MERS-CoV) virion, shown through
the process of immunolabeling the envelope proteins.
These are antibodies on virus spikes digitally colorized
on a transmission electron microscopic (TEM) image. Image Credit: NIAID via CDC.

with the creation of an antibody test—which can show if a person's immune system has been activated against the virus . . . According to the information currently available, the WHO believes the virus has an incubation period of between two to ten days.
“An antibody test will enable us to retrospectively test suspected patients
so we can gather a more accurate picture of how widespread the virus is,
and consequently, among other things, the true mortality rate.”5

Summary
A PERSON’S BLOOD BECOMES MORE POTENT OVER TIME AS THAT PERSON PREVAILS AND
OVERCOMES PATHOGENS AND PARASITES WITH ITS NEWLY FORMED ANTIBODIES IN
HIGH NUMBERS.
A person’s blood becomes more potent over time as that person prevails and overcomes pathogens and parasites with its newly
formed antibodies in high numbers. Antibodies have the secret locked away to defeat the germ that has invaded. The second
infection usually has minimal harm; hence, the wise blood has defeated the enemy. When a microbe pathogen or parasite invades
the blood, the immune system goes to work. The immune system acts like a Star Wars anti-missile action (Behe 1996). The rst
action is to recognize the invader. Bacteria have to be distinguished from blood cells, viruses from connective tissue, malaria
parasites from liver and spleen cells, etc. Unlike microbiologists, they cannot look at them under a microscope; rather, they have to
rely on a chemical sense of “taste/smell/touch.” They have “ ngers” of antibody arms. This is part of the fearfully and wonderfully
made design of the human body.
The body must solve the problem of binding to a speci c invader with a match of an estimated 1 in 100,000. There may be billions
or trillions of antibody types possibly needed in a lifetime.
There may be billions of different kinds of antibodies. Each antibody is made in a separate B lymphocyte cell. Once made, a factory
of antibodies is generated in many plasma cells, and memory cells recall the information for long-term storage of remembering
what was encountered. Immunization derives from the brilliant pioneering work of Edward Jenner and Louis Pasteur: they solved
the time problem of a quick and ef cient immune response for the body. Exposing the body to a weakened or “killed” pathogen
shrinks the time for the secondary response of IgG, allowing the body to ood the battle scene with prepared antibodies and
overwhelm intruders. The immune response, crafted wisely, was engineered with a mitigating mercy in light of a fallen world. It
remembers “germs” and responds swiftly with a counter defense that prolongs life.
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